1 |
Shen Y, Sun J, Sun X. Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress. J Nanobiotechnology 2023;21:84. [PMID: 36899348 DOI: 10.1186/s12951-023-01838-x] [Reference Citation Analysis]
|
2 |
Dong Q, Qi B, Zhang B, Zhuang X, Chen S, Zhou Q, Zhang BN, Li S. Overactivation of Norepinephrine-β2-Adrenergic Receptor Axis Promotes Corneal Neovascularization. Invest Ophthalmol Vis Sci 2023;64:20. [PMID: 36897151 DOI: 10.1167/iovs.64.3.20] [Reference Citation Analysis]
|
3 |
Sun J, Nie H, Pan P, Jiang Q, Liu C, Wang M, Deng Y, Yan B. Combined Anti-Angiogenic and Anti-Inflammatory Nanoformulation for Effective Treatment of Ocular Vascular Diseases. Int J Nanomedicine 2023;18:437-53. [PMID: 36718193 DOI: 10.2147/IJN.S387428] [Reference Citation Analysis]
|
4 |
Padjasek M, Qasem B, Cisło-pakuluk A, Marycz K. Cyclosporine A Delivery Platform for Veterinary Ophthalmology—A New Concept for Advanced Ophthalmology. Biomolecules 2022;12:1525. [DOI: 10.3390/biom12101525] [Reference Citation Analysis]
|
5 |
Zhang C, Yin Y, Zhao J, Li Y, Wang Y, Zhang Z, Niu L, Zheng Y. An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization. Int J Nanomedicine 2022;17:4911-31. [PMID: 36267540 DOI: 10.2147/IJN.S375570] [Reference Citation Analysis]
|
6 |
Yang LL, Zhou F, Xu Q, Ye T, Xiong H. Clinical Effect of Tongmai Fuming Decoction on Neovascular Ophthalmopathy. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-6. [DOI: 10.1155/2022/7327609] [Reference Citation Analysis]
|
7 |
Moritz M, Geszke-Moritz M. Mesoporous Materials as Elements of Modern Drug Delivery Systems for Anti-Inflammatory Agents: A Review of Recent Achievements. Pharmaceutics 2022;14:1542. [PMID: 35893798 DOI: 10.3390/pharmaceutics14081542] [Reference Citation Analysis]
|